Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

Healthcare Focused Private Equity Firm ARCHIMED Closes Second Fund, at €315M

 September

 18, 

2017

Healthcare-focused private equity firm ARCHIMED has raised a €315m fund in just four months

 September

 18, 

2017

ARCHIMED récolte 315 M€ pour son 2ème véhicule

 September

 18, 

2017

ARCHIMED atteint le hard cap pour son fonds II

 September

 18, 

2017

Healthcare specialist ARCHIMED banks 400% IRR from first exit

 April

 11, 

2017

Primo sponsors the Executive Master in Management specialized in Healthcare Business

 December

 9, 

2016

< 1 … 13 14 15 16 >
368
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top